American Association for Clinical Chemistry
1850 K Street NW
Suite 625
Washington
D.C.
20006-2213
United States
Tel: 800-892-1400-or-202-857-0717
Fax: 202-887-5093
Website: http://www.aacc.org/
Email: info@aacc.org
203 articles about American Association for Clinical Chemistry
-
AACC Releases Guidance Document on Using Point-of-Care Tests to Improve Patient Care
6/4/2020
AACC has issued a new guidance document detailing best practices that hospitals and other healthcare institutions should follow when running a point-of-care testing program.
-
To Prevent a Second Wave of COVID-19, AACC Calls on Senate to Include 5 Recommendations in Upcoming Coronavirus Bill
5/27/2020
Now that the latest coronavirus relief package, known as the Heroes Act, has moved forward to the U.S. Senate, AACC has sent a letter to Senate leadership outlining five key recommendations that will improve COVID-19 testing capacity across the U.S. AACC urges the Senate to ensure these recommendations are addressed within the Heroes Act, as they are critical to preventing a second wave of the pandemic.
-
Not All FDA-Authorized COVID-19 Antibody Tests Are Equally Reliable
5/14/2020
A first-of-its-kind study published in AACC's Clinical Chemistry journal compared the performance of two COVID-19 antibody tests and found that—even though both tests are FDA authorized—one produced more incorrect results than the other.
-
The Nation Needs More Evidence Before Relying on Home Test Collection Kits for COVID-19
4/30/2020
"We share the FDA's goal of expanding access to critical COVID-19 testing and encourage the agency to continue using its full authority to ensure laboratories are able to increase capacity as quickly as possible to flatten the curve of the pandemic.
-
AACC Launches Free Video Series to Help Explain COVID-19 Testing
4/29/2020
To address some of the confusion surrounding COVID-19 testing, AACC launched a video series in which leading laboratory experts answer common questions about tests for the pandemic.
-
Lab Experts Can Fill Gaps in FDA Regulation by Validating COVID-19 Antibody Tests
4/28/2020
Now that diagnostic companies can sell COVID-19 antibody tests without FDA authorization, healthcare teams should work closely with clinical laboratory experts to ensure that these tests are thoroughly validated and used appropriately.
-
AACC Commends Congress for Including Funding for Testing Improvements in the Latest Coronavirus Relief Package
4/23/2020
AACC applauds the U.S. Senate and House of Representatives for passing the Paycheck Protection Program and Health Care Enhancement Act.
-
AACC Announces 2020 Award Winners; Celebrates Achievements in Laboratory Medicine
4/22/2020
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2020 AACC and AACC Academy Awards.
-
The Federal Government Must Act on Supply Chains to Enable COVID-19 Testing in High Volumes
4/17/2020
Statement attributable to: Carmen L. Wiley , PhD President, American Association for Clinical Chemistry "The federal guidelines for the reopening of the United States released yesterday by the Tr
-
The Need for FDA to Regulate Poorly Performing Commercial COVID-19 Tests Should Not Hinder Laboratory-Developed Tests
4/14/2020
When the COVID-19 outbreak first reached the U.S., the country's response to the epidemic was hamstrung by extensive and unnecessary regulations causing a lack of testing capacity.
-
Novel Research in AACC's Clinical Chemistry Journal Shows That Vitamin D Supplements Do Not Prevent Osteoporotic Fractures
4/7/2020
A first-of-its-kind study published in AACC's Clinical Chemistry journal has found that low vitamin D levels alone do not cause osteoporotic fractures.
-
AACC Reschedules 2020 AACC Annual Scientific Meeting & Clinical Lab Expo to December to Ensure a Healthy and Safe Meeting Experience for Attendees
4/6/2020
AACC is pleased to announce that the organization will be able to preserve the complete 2020 AACC Annual Scientific Meeting & Clinical Lab Expo experience for its attendees by moving the meeting to December 13-17, 2020.
-
AACC Applauds the Senate for Updating Its Legislation to Ensure that All Patients Have Access to COVID-19 Testing
3/26/2020
AACC commends the U.S. Senate for passing the Coronavirus Aid, Relief, and Economic Security Act yesterday, which will provide vital support to Americans in the midst of the coronavirus outbreak.
-
When Mothers Receive Fentanyl Epidurals During Labor, the Fentanyl Gets Passed on to Their Babies
3/24/2020
Breaking research in AACC's The Journal of Applied Laboratory Medicine shows that the fentanyl in epidurals can pass on to babies during labor.
-
Families First Coronavirus Response Act Would Prohibit Insurers from Paying for Some COVID-19 Tests
3/14/2020
which we believe to be antithetical to the intent of the legislation and which may deter laboratories from performing the tests.
-
As U.S. Struggles to Get Coronavirus Testing Up and Running, AACC Calls on FDA to Allow Clinical Labs to Develop Their Own Tests for the Virus
2/28/2020
In a letter to the Food and Drug Administration, AACC is urging the agency to allow clinical laboratories to develop coronavirus tests without going through FDA review.
-
The Journal of Applied Laboratory Medicine Is Now Indexed in PubMed
10/30/2019
AACC is pleased to announce that its peer-reviewed publication The Journal of Applied Laboratory Medicine has been accepted for indexing in PubMed, one of the largest and most respected databases of medical research in the world.
-
AACC's Journals, Clinical Chemistry and The Journal of Applied Laboratory Medicine, to Be Published through Oxford University Press
10/11/2019
AACC is pleased to announce a publishing partnership with Oxford University Press for its peer-reviewed journals, Clinical Chemistry and The Journal of Applied Laboratory Medicine.
-
True Diagnostics™ and Veravas, Inc. Announce Strategic Alliance in the Commercialization of VeraTest Biotin™
9/3/2019
True Diagnostics, Inc. and Veravas announced their Strategic Alliance in the commercialization of VeraTest Biotin, a portable and easy-to-use digital qualitative test that can rapidly screen patient samples to determine if significant biotin is present, helping safeguard against potential biotin interference.
-
BBI Solutions demonstrates mobile diagnostic capabilities at AACC tradeshow
8/15/2019
BBI Solutions demonstrated how its pioneering point of care testing enables users to securely read, interpret and transmit rapid assay results at the world’s largest laboratory medicine tradeshow, the American Association for Clinical Chemistry annual conference.